Cold Chain

In this part of his Pharma Commerce video interview, Dan Gagnon, UPS Healthcare’s VP of Global Strategy & Acquisition Integration, dives into the challenges of safeguarding these products, while also sharing his keys to sustaining stability in the ‘recession resistant’ healthcare industry.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Dan Gagnon, UPS Healthcare’s VP of Global Strategy & Acquisition Integration, discusses the development of frozen/cold biologics when it comes to the logistics space, along with how the companies themselves have changed over the years.

The San Antonio facility will be taking this biomanufacturing initiative by the end of Q3 2024.

The investment is expected to help enhance the company temperature-controlled services in the Netherlands, France, Italy, and Hungary.

The deal also adds a spread of supply chain efficiency, sustainability, and patient safety outcomes to the mix.

The company’s European Hub facility in Roermond is expanding by over 235,000 square feet, and will be dedicated to accommodating freezer farm capacity.

The 53,000 square-foot facility is expected to become a Northeastern biotech hub, and will be home to various CGT services.

The company's latest service provides risk and quality management for the pharma and healthcare sectors.

The Netherlands plant is expected to provide solutions that can help further the development of advanced therapies.

The document reiterates the company’s commitment to ESG principles, including carbon neutrality by 2030.

The company has financially committed $13.1 million into the project.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Cathy O'Brien, VP of Sales, UPS Healthcare discusses current technology that the pharma industry is adopting when it comes to sustainability.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Cathy O'Brien, VP of Sales, UPS Healthcare discusses her masterclass on delivering agility in supply chains by building a multimodal cold chain network while also reducing risks at LogiPharma Europe 2024.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Martin Hawes, Global Head of Product Development, Tower Cold Chain offers insights on the future of cell & gene therapies when it comes to cold chain storage.

A one-on-one with Thermo Fisher’s Wilfredo Marin, who dives into the value of ultra-low temperature storage, the need for flexibility in the cold chain logistics space, and more.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, suggests how to improve visibility and risk management for cold chain shipping.

In an interview with Pharma Commerce Editor Nicholas Saraceno, Niklas Adamsson, COO, Envirotainer, offers his thoughts on how changing customer needs are affecting cold chain logistics.

Session addresses the challenges of implementing autologous/allogeneic cell gene therapies into scalable networks.

Panel discussion uncovers how to alter one’s digital know-how for use in temperature-controlled supply chain.

The collaboration strengthens the capabilities of Tower’s advanced passive temperature-controlled containers.

The new products offer more temperature control and sustainability benefits.

The first commercial shipments are scheduled for mid-April.

Although time has welcomed novel advances in the space, new challenges pertaining to data and the physical technology, along with visibility and sustainability, are emerging.

The CRO’s FortreaRx doubles in size, including a boost in cold chain storage, while also continuing to improve its patient access services.

The financial commitment features construction of new warehouses in Pennsylvania and North Carolina.

DB Schenker, JAS, Medista, MSC Air Cargo, OnAsset Intelligence, and xpd global round out the latest additions.

The latest move expands the company’s storage capacity and cold chain capabilities.

Over the past year, Pharma Commerce’s digital coverage featured a variety of subject matters, ranging from how to calculate 340B prices, to the future of pharmacy.

Items in this sector ranged touched on topics such as pharma shipping, container technology, and sustainability.

MoU aims to align the pharmaceutical and cold chain sectors by boosting operations.